Heliang Liu Selected Research

Silicosis

5/2024	miR-455-3p regulates lymphangiogenesis in silicosis by regulating VEGF-C/VEGFR3.
4/2024	Paeoniflorin mitigates MMP-12 inflammation in silicosis via Yang-Yin-Qing-Fei Decoction in murine models.
12/2023	Lipid characteristics of lung tissue in silicosis rat model were studied based on lipid metabolomics.
12/2023	Exercise training inhibits macrophage-derived IL-17A-CXCL5-CXCR2 inflammatory axis to attenuate pulmonary fibrosis in mice exposed to silica.
7/2023	miR-29a-3p Regulates Autophagy by Targeting Akt3-Mediated mTOR in SiO2-Induced Lung Fibrosis.
1/2023	Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway.
1/2023	Bioinformatics analysis reveals lipid metabolism may play an important role in the SiO2-stimulated rat model.
11/2022	Effect of Sex Differences in Silicotic Mice.
10/2022	Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica.
8/2022	The regulatory effect of pulmonary lymphatic drainage on silicosis fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heliang Liu Research Topics

Disease

28	Silicosis 05/2024 - 01/2019
15	Fibrosis (Cirrhosis) 05/2024 - 10/2019
9	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2023 - 10/2019
5	Inflammation (Inflammations) 04/2024 - 01/2020
5	Neoplasms (Cancer) 05/2018 - 03/2009
4	Pneumonia (Pneumonitis) 05/2024 - 01/2021
4	Occupational Diseases (Occupational Disease) 12/2023 - 06/2020
2	Rosacea (Acne Rosacea) 03/2023 - 01/2022
2	Hyperplasia 03/2023 - 05/2022
2	Cicatrix (Scar) 12/2021 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2014 - 03/2009
2	Stomach Neoplasms (Stomach Cancer) 04/2014 - 09/2010
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2004 - 03/2002
1	Pneumoconiosis 07/2023
1	Atherosclerosis 01/2023
1	Poisoning 12/2022
1	Necrosis 04/2022
1	Erythema 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 12/2021
1	B-Cell Leukemia (Leukemia, B Cell) 07/2020
1	Lymphoma (Lymphomas) 07/2020
1	Lung Diseases (Lung Disease) 02/2020
1	Lung Neoplasms (Lung Cancer) 05/2018
1	Fistula 11/2014
1	Infections 11/2014
1	Carcinoma (Carcinomatosis) 04/2014

Drug/Important Bio-Agent (IBA)

27	Silicon Dioxide (Silica)FDA LinkGeneric 05/2024 - 10/2019
5	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2020
4	CollagenIBA 12/2023 - 12/2021
3	LipidsIBA 12/2023 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2020
3	goralatideIBA 09/2021 - 10/2019
2	Vascular Endothelial Growth Factor CIBA 05/2024 - 04/2021
2	Scavenger Receptors (Scavenger Receptor)IBA 12/2023 - 01/2019
2	Toll-Like Receptor 4IBA 12/2023 - 05/2022
2	3-methyladenineIBA 07/2023 - 07/2020
2	CytokinesIBA 01/2023 - 09/2010
2	SiliconIBA 05/2022 - 10/2021
2	Thalidomide (Thalomid)FDA Link 05/2022 - 01/2022
2	oxidized low density lipoproteinIBA 01/2020 - 01/2019
1	LuciferasesIBA 05/2024
1	peoniflorinIBA 04/2024
1	Ether (Diethyl Ether)IBA 12/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 12/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	NLR ProteinsIBA 12/2023
1	Sirolimus (Rapamycin)FDA Link 07/2023
1	SuspensionsIBA 01/2023
1	CSK Tyrosine-Protein KinaseIBA 01/2023
1	src-Family KinasesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	SU 6656IBA 01/2023
1	CarcinogensIBA 12/2022
1	ArsenicIBA 12/2022
1	MetalloidsIBA 12/2022
1	VimentinIBA 11/2022
1	InterleukinsIBA 11/2022
1	Collagen Type I (Type I Collagen)IBA 11/2022
1	QuartzIBA 10/2022
1	tanshinone II A sodium sulfonateIBA 08/2022
1	Connective Tissue Growth FactorIBA 04/2022
1	S100 Calcium-Binding Protein A4IBA 04/2022
1	EnzymesIBA 03/2022
1	GalactosidasesIBA 01/2022
1	QuercetinIBA 01/2022
1	Actins (F Actin)IBA 12/2021
1	indium-bleomycinIBA 12/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2021
1	UbiquitinIBA 12/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021
1	IronIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	TubulinIBA 01/2021
1	ElastinIBA 01/2021
1	ABT-737IBA 07/2020
1	Class III Phosphatidylinositol 3-KinasesIBA 07/2020
1	Long Noncoding RNAIBA 05/2020
1	Tiopronin (Thiola)FDA Link 03/2020
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 02/2020
1	Complement Factor B (Factor B)IBA 02/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	Peptides (Polypeptides)IBA 10/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019
1	AngiotensinsIBA 10/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	hydroxycamptothecinumIBA 05/2018
1	homocamptothecinIBA 05/2018
1	dehydroacetic acid (DHAS)IBA 11/2014
1	HeliumIBA 10/2014
1	ArgonIBA 10/2014
1	Neuropilin-2IBA 04/2014

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024
1	Injections 03/2023
1	Drug Therapy (Chemotherapy) 05/2018
1	Cryotherapy (Therapy, Cold) 10/2014
1	Local Anesthesia 10/2014
1	Cryosurgery 10/2014